Tenon Medical Q1 2024 GAAP EPS $(1.25) Beats $(1.34) Estimate, Sales $719.00K Miss $783.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Tenon Medical (NASDAQ:TNON) reported Q1 2024 earnings with a GAAP EPS of $(1.25), surpassing the $(1.34) estimate, and sales of $719.00K, missing the $783.00K estimate. The EPS represents a 70.93% improvement, and sales a 66.05% increase over the same period last year.
May 14, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Tenon Medical reported a smaller than expected quarterly loss and a significant year-over-year improvement in both earnings and sales, though sales missed estimates.
The mixed results with an EPS beat but a miss on sales forecasts could lead to a neutral short-term impact on TNON's stock price. The significant improvement in earnings and sales year-over-year is positive, but the sales miss might temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100